Epsilogen is a biopharmaceutical company focused on developing monoclonal antibody therapeutics targeting complex diseases, with an emphasis on harnessing the immune system to fight infections and cancers. The company utilizes its proprietary technology platform to create innovative therapies that aim to improve patient outcomes.